Urinary Tract Infection Treatment: Antibiotics for the Management of Urinary Tract Infection
The Urinary Tract Infection (UTI) treatment market is anticipated to witness growth since antibiotics are the only treatment for the management of the same. Loss of patent rights by branded drugs and the emergence of branded generics and generic drugs are among factors that are likely to boost the urinary tract infection treatment market.
Urinary Tract Infection (UTI) Treatment Market – Key Research Findings
Urinary tract infection treatment market size valuated in 2018 was ~US$ 10 Bn.
The UTI treatment market is anticipated to grow at a CAGR of ~2% over 2019-2029.
Europe is expected to remain the leading regional market for urinary tract infection treatment.
Leading companies operating in the UTI treatment market are focusing on expanding production facilities and establishing long-term distribution contracts with major local distribution companies, to stay competitive among their peers in the urinary tract infection market.
Quinolones, in terms of drug class, are projected to lead the way in urinary tract infection treatment market over the forecast period.
Top 3 Factors Shaping the Urinary Tract Infection Treatment Market
Increasing UTI Prevalence to Drive the Urinary Tract Infection Treatment Market
Urinary tract infection is more common in women compared to men due to their anatomy. Several women experience urinary tract infection more than once in their lifetime. According to certain studies, urinary tract infection affects approximately 150 million people globally. In addition, approximately 11% women visit one physician in a year for urinary tract infection treatment. Hormonal changes, improper personal hygiene, use of catheters, and other factors are some of the main causes of urinary tract infection. With an increase in the prevalence of urinary tract infection, the urinary tract infection treatment market is expected to witness significant growth in the coming years.
Rising Demand for Antibiotics to Contribute to the Demand for Urinary Tract Infection Treatment
Antibiotics are the only treatment options available for urinary tract infection. According to the severity of the infection, a wide range of antibiotics are prescribed. For instance, for uncomplicated urinary tract infection treatment, fluoroquinolones, trimethoprim/sulfamethoxazole, and aminoglycosides are prescribed as initial treatment. Similarly, for complicated urinary tract infection treatment cases, fluoroquinolones such as ciprofloxacin or ofloxacin are prescribed in case of less severe infection. Apart from these, loss of patent rights of branded drugs and the availability of cost-effective antibiotics from generic companies are among factors that are likely to spur the growth of the urinary tract infection treatment market.
Rising Use of Urinary Catheters and Other Drainage Devices Likely to Offer an Uptick to Urinary Tract Infection Treatment Market Growth
The rising incidence of chronic kidney diseases, such as bladder cancer and renal failure, has led to the increase usage of catheters and other drainage devices in patients. Patients using urinary catheters are more likely to acquire complicated UTI. According to World Health Organization (WHO), the risk of bacteriuria is approximately 5% per day for patients using urinary catheters and 40% suffer from nosocomial infections. Certain factors, such as prolonged duration of catheterisation, not receiving system therapy of antibiotics, bacterial colonisation in drainage bags, rapid fata underlying diseases, and others, are likely to result in catheter-associated urinary tract infection. Hence, increase in the usage of urinary catheters will foster the growth of the urinary tract infection treatment market.
Urinary Tract Infection Treatment Market Structure Analysis
Key comapnies spearheading the comeptition landscape of the global UTI treatment market, such as Bayer AG, are focused on stregthening their R&D activties for the development of novel drug molecules.
FMI analyses that a majority of leading players, for instance Allergan Plc, in urinary tract infection treatment market are also prioritizing strategic collaborations and acquisitions to achieve broader availability on market and tap the unmet needs of patients.
Market Set to Grow by 1.2X between 2019 and 2029
The urinary tract infection treatment market is expected to register considerable growth owing to the rising prevalence of urinary tract infections and increase in the number of hospital visits for urinary tract infection testing as well as treatment. Moreover, the high demand for antibiotics in urinary tract infection treatment and growth in the number of generic players is likely to propel the growth of the urinary tract infection treatment market.
Emerging Countries Foster New Growth Opportunities for the Urinary Tract Infection Treatment Market
Europe holds a prominent revenue share among other regions in the global urinary tract infection treatment market in 2019. However, developing countries, such as China, India, and South Korea, have witnessed growth in the urinary tract infection treatment market due to increasing awareness about urinary tract infection treatment and rising government initiatives for healthcare spending.
The Broader Perspective
Various manufacturers are engaged in strategic acquisitions and collaborations with different companies and distribution channels to increase the sales of their products and enhance their business operations.
Quinolones holds a significant share among all other drug class
Cephalosporin accounts for a significant share after Quinolones
Penicillin & Combinations account for nearly US$ 500 Mn
Complicated UTI remains among the top indications with a CAGR of nearly 3%
Uncomplicated UTI holds a significantly low share as compared to uncomplicated UTI
Retail pharmacies is among the prominent distribution channels with a revenue share of nearly 60%
The drug store segment has a comparatively low share among all other distribution channels
How Growth will Unfold
The prevalence of UTI is increasing at an alarming rate. Improper use of disposable hygiene products for personal use, administration of catheters in urethra, sexual activity, menopause, and certain other factors are anticipated to boost the urinary tract infection treatment market. The growing demand for antibiotics and the low cost of generic drugs is also expected to spur the growth of the urinary tract infection treatment market.
Quinolones | Cephalosporin
* This data is only a representation. Actual data may vary and will be available in report.Click Here To Know How The Growth Will Unfold
Custom Market Research Services
FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.
Urinary Tract Infection (UTI) Treatment Market: Global Industry Analysis 2014-2018 & Opportunity Assessment 2019-2029
A recent market study published by FMI on the urinary tract infection treatment market during 2014-2018 & forecast for 2019-2029 offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the urinary tract infection treatment market, the growth prospects of the market have been obtained with maximum precision.
UTI (Urinary Tract Infection) Treatment Market Taxonomy
The global urinary tract infection treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
By Drug Class
- Penicillin & Combinations
- Aminoglycoside Antibiotics
- Sulphonamides (Sulfamethoxazole, Trimethoprim)
- Azoles and Amphotericin B
- Tetracycline (Doxycycline)
- Nitrofurans (Nitrofurantoin)
- Complicated Urinary Tract Infection
- Uncomplicated Urinary Tract Infection
By Distribution Channel
- Hospital Pharmacies
- Gynecology and Urology Clinics
- Drug Stores
- Retail Pharmacies
- Online Drug Stores
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa
The report commences with the executive summary of the urinary tract infection treatment market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the urinary tract infection treatment market.
Readers can find the detailed taxonomy and the definition of the urinary tract infection treatment market in this chapter, which will help them understand the basic information about the urinary tract infection treatment market. This section also highlights the inclusions and exclusions, which help the reader understand the scope of the urinary tract infection treatment market report.
The report provides key market trends that are expected to impact the market growth significantly during the forecast period. Detailed industry trends are provided in this section, along with key market developments and product innovations.
This section explains the global market value analysis and forecast for the urinary tract infection treatment market between the forecast periods of 2014-2029. This chapter includes the detailed analysis of the historical urinary tract infection treatment market, along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year (2019 – 2020), and an incremental opportunity for the forecast period (2019 – 2029).
This chapter explains the key macro-economic factors that are expected to influence the growth of the urinary tract infection treatment market over the forecast period. Along with macro-economic factors, this section also highlights the opportunity analysis for the urinary tract infection treatment market. Moreover, this chapter highlights the key market dynamics of the urinary tract infection treatment market, which include the drivers, restraints, and trends. Readers will understand the key trends followed by the leading manufacturers in the urinary tract infection treatment market.
Based on drug class, the urinary tract infection treatment market is segmented into Penicillin & Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides (Sulfamethoxazole, Trimethoprim), Azoles and Amphotericin B, Tetracycline (Doxycycline), Nitrofurans (Nitrofurantoin), and others. In this chapter, readers can find information about the key trends and developments in the urinary tract infection treatment market and market attractiveness analysis based on the drug class.
Based on indication, the urinary tract infection treatment market is segmented complicated urinary tract infection and uncomplicated urinary tract infection. In this chapter, readers can find information about the key trends and developments in the urinary tract infection treatment market and market attractiveness analysis based on the indication.
This chapter provides details about the urinary tract infection treatment market on the basis of distribution channel, and has been classified into hospital pharmacies, gynecology and urology clinics, drug stores, retail pharmacies, and online drug stores. In this chapter, readers can understand the market attractive analysis based on distribution channel.
This chapter explains how the urinary tract infection treatment market will grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).
This chapter includes a detailed analysis of the growth of the North America urinary tract infection treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, regulations, and market growth based on the distribution channel and countries in North America.
Readers can find detailed information about regional trends, which are impacting the growth of the Latin America urinary tract infection treatment market. This chapter also includes the growth prospects of the urinary tract infection treatment market in the leading LATAM countries such as Brazil, Mexico, Argentina, and the Rest of Latin America.
Important growth prospects of the urinary tract infection treatment market based on its distribution channel in several countries, such as Germany, the UK, France, Spain, Italy, Russia, and the Rest of Europe, are included in this chapter.
India, Indonesia, Thailand , Malaysia are the leading countries in the South Asia region, which are the prime subjects of assessment to obtain the growth prospects of the South Asia urinary tract infection treatment market in this chapter. Readers can find detailed information about the growth parameters of the South Asia urinary tract infection treatment market during the period 2019-2029.
This chapter highlights the growth of the urinary tract infection treatment market in the East Asia by focusing on China, Japan, and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the urinary tract infection treatment market in East Asia.
In this chapter, Australia and New Zealand are among the leading countries in the Oceania region, which are the prime subjects of assessment to obtain the growth prospects of the Oceania urinary tract infection treatment market.
This chapter provides information about how the urinary tract infection treatment market will grow in the major countries in the MEA region, such as GCC Countries, South Africa, Turkey, Northern Africa and the rest of MEA, during the forecast period 2019 - 2029.
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the urinary tract infection treatment report.
This chapter helps readers understand the research methodology followed to obtain the various conclusions as well as important qualitative and quantitative information about the urinary tract infection treatment market.
How the research was conducted?
- C - Level Executives
- Marketing Directors
- Sales Heads
- Portfolio Managers
- Purchasing Managers
- Medical Officers
- Strategy Advisors
- R&D Managers
- Product Manufacturers
- Pharmacists / Pharmacy Benefit Managers
- Hospital Purchasing Departments
- Physicians / Nursing Managers
- Industry Experts
- Current Market Dynamics and Challenges
- Market Characteristics
- Market Performance and Growth Quadrants
- Competition Structure and Market Structure
- Strategic Growth Initiatives
- Disease Patterns, Treatment and Prescription Patterns
- Regulatory and Reimbursement Landscape
- Products in Pipeline and Clinical Development
- Near-term and Long-term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
- Industry Magazines
- National Institute for Health and Care Excellence
- European Association of Urology
- Company Press Releases
- Annual Reports and Investor Presentations
- Peer-reviewed Journals
- Government Websites and Publications
- Trade Websites
- Clinical Trial Registries
- Country-specific Regulatory Authorities
- World Bank, WHO, IMF, OECD
Primary Interview Splits